The Bcl-2 inhibitor Venetoclax promotes CLL cell apoptosis (39), and induces rapid and pronounced activation and mitochondrial translocation of Bax in cell lines of acute myeloid leukemia (40). Here, BCL2 is linked to acute myeloid leukemia.